PGAM1 and non-small cell lung carcinoma: The results confirmed that PGAM1 displayed markedly higher expression in NSCLC tissues than in in noncancerous tissues, and the immunoreactivity of PGAM1 was mostly distributed in both the cytoplasm and cell membrane (Fig. 2c).